Entering text into the input field will update the search result below

SUSRF Surgical Science Sweden AB (publ)
Stock Price & Overview

$11.840.00 (0.00%)11:08 AM 12/01/23
Pink Limited Info | $USD | Delayed


Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Prev. Close

Quant Ranking

People Also Follow

Company Profile

Surgical Science Sweden AB (publ) logo
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based medical training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; LAP Mentor simulator provides laparoscopic training; and LapSim essence, a portable and ready-to-use VR laparoscopic simulator. The company also provides EndoSim system, an endoscopy simulator that delivers medical simulation training; TeamSim, a dynamic platform for inter-professional education development taking surgery simulation into the real world teamwork; Simball Box, which offers feedback on velocity with tutorial task videos showing a preferred approach; GI Mentor, the gold standard simulator for the training of gastrointestinal upper and lower endoscopic procedures; Ultrasound Mentor, a cross-specialty solution for ultrasound training; Angio Mentor simulator provides endovascular training; Spine Mentor, a virtual reality training simulator for minimal invasive spine surgery; GI-BRONCH Mentor platform that offers a combined system for GI endoscopy and flexible bronchoscopy training; Perc Mentor simulator provides ultrasound and fluoroscopy training; ARTHRO Mentor, an advanced arthroscopic training simulator; PELVIC Mentor simulator provides anatomy and pelvic exam training; URO Mentor, a virtual reality simulator for endourology training; simbionix simulators; and robotic surgery simulators. Surgical Science AB was incorporated in 1997 and is headquartered in Gothenburg, Sweden.
  • Drakegatan 7 A, 3 tr.
  • Gothenburg, 412 50
  • Sweden
Phone Number
46 3 17 41 65 60
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.